# Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

Study · id `cardio:ct-nct02648464` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02648464](<https://clinicaltrials.gov/study/NCT02648464>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02648464

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.

## Technical summary

Registry record NCT02648464. Randomized; triple masking; primary purpose treatment. Start 2016-02-01 (actual); primary completion 2019-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 125 participants (enrolled count; ClinicalTrials.gov record NCT02648464, source copy `cardio:ctgov-nct02648464-2020-06-09`, retrieved 2026-10-26)
- Started: 2016-02-01 (actual) (ClinicalTrials.gov record NCT02648464, source copy `cardio:ctgov-nct02648464-2020-06-09`, retrieved 2026-10-26)
- Primary completion: 2019-12-31 (actual) (ClinicalTrials.gov record NCT02648464, source copy `cardio:ctgov-nct02648464-2020-06-09`, retrieved 2026-10-26)
- Completion: 2019-12-31 (actual) (ClinicalTrials.gov record NCT02648464, source copy `cardio:ctgov-nct02648464-2020-06-09`, retrieved 2026-10-26)
- Countries: Finland (ClinicalTrials.gov record NCT02648464, source copy `cardio:ctgov-nct02648464-2020-06-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02648464-2020-06-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
- Acronym: OXI
- Condition: Myocardial Infarction
- Condition: Acute Coronary Syndrome
- Condition: Inflammation
- Condition: Hydroxychloroquine
- Condition: Antirheumatic Agents
- Condition: Cardiovascular Diseases
- Intervention (Drug): Hydroxychloroquine
- Intervention (Drug): Placebo
- Lead sponsor: Helsinki University Central Hospital
- Lead sponsor class: OTHER
- Collaborator: Finnish Foundation for Cardiovascular Research
- Collaborator class: OTHER
- Collaborator: Orion Corporation, Orion Pharma
- Collaborator class: INDUSTRY
- Collaborator: Aarne Koskelo Foundation
- Collaborator class: OTHER
- Collaborator: Finnish Cultural Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Helsinki University Central Hospital (`cardio:org-helsinki-university-central-hospital`)
- Registry lists this organization as a collaborator: Orion Corporation, Orion Pharma (`cardio:org-orion-corporation-orion-pharma`)

## Provenance

Content hash: 997f5c778ff38602658351a15f0b0fee024e38b4ee86ef28bf2f5e9bfeb911e3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
